• No results found

[PDF] Top 20 Targeted therapies for diarrhea-predominant irritable bowel syndrome

Has 10000 "Targeted therapies for diarrhea-predominant irritable bowel syndrome" found on our website. Below are the top 20 most common "Targeted therapies for diarrhea-predominant irritable bowel syndrome".

Targeted therapies for diarrhea-predominant irritable bowel syndrome

Targeted therapies for diarrhea-predominant irritable bowel syndrome

... compared desipramine and placebo in a subset of 431 patients with functional bowel disorders, more than 80% of whom had IBS. Patients were randomized to receive pharmacotherapy (n = 216) with either desipramine ... See full document

32

Original Article The therapeutic effect of low-dose amitriptyline on patients with refractory diarrhea-predominant irritable bowel syndrome and its 1-year follow-up study

Original Article The therapeutic effect of low-dose amitriptyline on patients with refractory diarrhea-predominant irritable bowel syndrome and its 1-year follow-up study

... distention, bowel sound hyperfunction, and bowel satisfaction was defined as the visu- al analog scale score ...of diarrhea symptoms was defined as an improvement of one or two levels with respect to ... See full document

8

Moxibustion treatment for diarrhea predominant irritable bowel syndrome: study protocol for a randomized controlled trial

Moxibustion treatment for diarrhea predominant irritable bowel syndrome: study protocol for a randomized controlled trial

... the Bowel Disease Clinic of the Shanghai Research Institute of Acupuncture and Meridian; the Department of Acupuncture-Moxibustion of the Yueyang Integrated Chinese and Western Medicine Hospital at the Shanghai ... See full document

6

A Clostridia rich microbiota enhances bile acid excretion in diarrhea predominant irritable bowel syndrome

A Clostridia rich microbiota enhances bile acid excretion in diarrhea predominant irritable bowel syndrome

... Normally, BAs are primarily synthesized by the rate- limiting enzyme cholesterol 7α-hydroxylase (CYP7A1) and then conju- gated with amino acids in the liver (22). Most conjugated BAs released into the intestine are ... See full document

14

Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

... brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61(9):1284–1290. 7. Liu HN, Wu H, Chen YZ, Chen YJ, Shen XZ, Liu TT. Altered molecular ... See full document

11

Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel"?

Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel"?

... with predominant diarrhea subtype, there is increased serotonin production leading to increase in ...with diarrhea predominant IBS which suggests an overstimulation of secretomotor neurons by ... See full document

10

Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

... of bowel pre- paration on the mucosal-associated microbiota, colonic mucosal samples were collected from patients that did not receive a bowel preparation prior to the ... See full document

9

Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea

Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea

... or antispasmodics clinical experience is existent and acces- sibility to them is eased by low cost and over-the-counter purchasing. Clinical use will show whether eluxadoline might prove a suitable second-line treatment ... See full document

12

Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation

Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation

... in diarrhea- predominant IBS ...the diarrhea-predominant ...in diarrhea-predominant IBS patients varied in comparison with that in other sub- types of IBS patients, it would be ... See full document

9

Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome

Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome

... Abstract: Irritable bowel syndrome (IBS) is a functional disease with persisting gastrointes- tinal symptoms that has been classified into four ...from diarrhea-predominant ...with ... See full document

6

Diarrhea-predominant irritable bowel syndrome: creation of an electronic version of a patient-reported outcome instrument by conversion from a pen-and-paper version and evaluation of their equivalence

Diarrhea-predominant irritable bowel syndrome: creation of an electronic version of a patient-reported outcome instrument by conversion from a pen-and-paper version and evaluation of their equivalence

... (past week, month, or 3 months for the IBS-D Daily Symptom Diary; past day, month, or 3 months for the IBS-D Symptom Event Log). The report-history section was populated with sample data, and subjects were asked to ... See full document

13

Original Article A randomized controlled trial on itopride in the treatment of patients with irritable bowel syndrome with diarrhea accompanied by abdominal distension

Original Article A randomized controlled trial on itopride in the treatment of patients with irritable bowel syndrome with diarrhea accompanied by abdominal distension

... Irritable bowel syndrome (IBS) is a common functional bowel disease in the digestive de- partment, it is also a syndrome characterized by diarrhea, abdominal distension, ... See full document

7

Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients

Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients

... Irritable bowel syndrome (IBS) affects an estimated 10-15% of people in western cultures ...and diarrhea [2] and can negatively impact health-related quality of life ...clude: diarrhea ... See full document

12

High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-predominant Irritable Bowel Syndrome Based on Rome III Criteria.

High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-predominant Irritable Bowel Syndrome Based on Rome III Criteria.

... Strengths of our study include the methodology used. Several previous studies have claimed an association between symptoms that are compatible with D-IBS and idiopathic BAD, yet have been limited by their retrospective ... See full document

14

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom

... Irritable bowel syndrome (IBS) is a chronic and episodic gastrointestinal (GI) ...altered bowel function, with the predominant bowel symptom determining the subclassification of ... See full document

12

Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review

Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review

... both diarrhea and constipation is ...their diarrhea or their constipated states, and then combine those popula- tions with either D-IBS or C-IBS patients for indications of nonconstipated IBS patients or ... See full document

10

Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome

Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome

... IBS: irritable bowel syndrome; IBS‑D: diarrheapredominant irritable bowel syndrome; IBS‑C: constipation‑predominant irritable bowel ... See full document

10

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome

... Eluxadoline is a mu-opioid receptor agonist, delta-opioid receptor antagonist, and kappa-opioid receptor agonist indicated for the management of symptoms of IBS-D in adult patients. It exhibits a mechanism of action in ... See full document

14

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome

... Abstract: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal dis- orders ...with diarrhea-predominant IBS (IBS-D) comprise a substantial proportion of the overall ... See full document

11

A study on cytokine response in diarrhea predominant irritable bowel syndrome.

A study on cytokine response in diarrhea predominant irritable bowel syndrome.

... Work from the Barcelona group 17 18 has shown that metabolism and absorption of gas is altered in IBS leading to gas entrapment in bowel. It has also proposed an increased perception of gas due to stimulation of ... See full document

93

Show all 10000 documents...